Spatial Domain
Spatial Domain (Tier 1)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__88_A7,1 | Lung | Primary cancer | 3,240 | Stromal | 26.5% | 0.80 | 0.53 |
| NSCLC_38242124__IMC__88_A7,10 | Lung | Primary cancer | 2,113 | Tumor/Malignant | 53.7% | 0.93 | 0.22 |
| NSCLC_38242124__IMC__88_A7,11 | Lung | Primary cancer | 3,179 | Tumor/Malignant | 50.0% | 0.99 | 0.05 |
| NSCLC_38242124__IMC__88_A7,12 | Lung | Primary cancer | 861 | Stromal | 28.5% | 0.69 | 0.72 |
| NSCLC_38242124__IMC__88_A7,13 | Lung | Primary cancer | 3,282 | Tumor/Malignant | 42.5% | 0.95 | 0.23 |
| NSCLC_38242124__IMC__88_A7,14 | Lung | Primary cancer | 1,858 | Stromal | 39.3% | 0.79 | 0.49 |
| NSCLC_38242124__IMC__88_A7,15 | Lung | Primary cancer | 3,912 | Tumor/Malignant | 46.1% | 0.93 | 0.21 |
| NSCLC_38242124__IMC__88_A7,16 | Lung | Primary cancer | 3,866 | Tumor/Malignant | 59.4% | 0.94 | 0.18 |
| NSCLC_38242124__IMC__88_A7,2 | Lung | Primary cancer | 2,931 | Tumor/Malignant | 35.0% | 0.83 | 0.46 |
| NSCLC_38242124__IMC__88_A7,3 | Lung | Primary cancer | 3,583 | Tumor/Malignant | 55.3% | 0.96 | 0.13 |
| NSCLC_38242124__IMC__88_A7,4 | Lung | Primary cancer | 2,848 | Stromal | 35.4% | 0.99 | 0.06 |
| NSCLC_38242124__IMC__88_A7,5 | Lung | Primary cancer | 2,444 | Tumor/Malignant | 57.0% | 0.94 | 0.15 |
| NSCLC_38242124__IMC__88_A7,6 | Lung | Primary cancer | 4,004 | Tumor/Malignant | 71.9% | 0.97 | 0.11 |
| NSCLC_38242124__IMC__88_A7,7 | Lung | Primary cancer | 3,483 | Tumor/Malignant | 81.7% | 0.98 | 0.08 |
| NSCLC_38242124__IMC__88_A7,8 | Lung | Primary cancer | 3,840 | Tumor/Malignant | 92.0% | 0.99 | 0.03 |
| NSCLC_38242124__IMC__88_A7,9 | Lung | Primary cancer | 2,058 | Other | 31.5% | 0.58 | 0.74 |
| NSCLC_38242124__IMC__88_A8,1 | Lung | Primary cancer | 3,439 | Tumor/Malignant | 33.0% | 0.95 | 0.17 |
| NSCLC_38242124__IMC__88_A8,10 | Lung | Primary cancer | 2,277 | Tumor/Malignant | 43.0% | 1.00 | 0.04 |
| NSCLC_38242124__IMC__88_A8,11 | Lung | Primary cancer | 2,263 | Tumor/Malignant | 46.6% | 0.92 | 0.31 |
| NSCLC_38242124__IMC__88_A8,12 | Lung | Primary cancer | 2,130 | Stromal | 41.2% | 0.52 | 0.91 |
Spatial Domain (Tier 2)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__88_A7,1 | Lung | Primary cancer | 3,240 | Tumor/Malignant | 21.5% | 0.93 | 0.25 |
| NSCLC_38242124__IMC__88_A7,10 | Lung | Primary cancer | 2,113 | Tumor/Malignant | 34.0% | 1.00 | 0.05 |
| NSCLC_38242124__IMC__88_A7,11 | Lung | Primary cancer | 3,179 | Tumor/Malignant | 53.4% | 0.99 | 0.07 |
| NSCLC_38242124__IMC__88_A7,12 | Lung | Primary cancer | 861 | Other | 25.4% | 0.38 | 1.01 |
| NSCLC_38242124__IMC__88_A7,13 | Lung | Primary cancer | 3,282 | Tumor/Malignant | 34.8% | 0.76 | 0.60 |
| NSCLC_38242124__IMC__88_A7,14 | Lung | Primary cancer | 1,858 | Stromal | 39.9% | 0.99 | 0.07 |
| NSCLC_38242124__IMC__88_A7,15 | Lung | Primary cancer | 3,912 | Tumor/Malignant | 41.9% | 0.95 | 0.17 |
| NSCLC_38242124__IMC__88_A7,16 | Lung | Primary cancer | 3,866 | Tumor/Malignant | 56.0% | 0.95 | 0.15 |
| NSCLC_38242124__IMC__88_A7,2 | Lung | Primary cancer | 2,931 | Tumor/Malignant | 24.6% | 0.90 | 0.33 |
| NSCLC_38242124__IMC__88_A7,3 | Lung | Primary cancer | 3,583 | Tumor/Malignant | 38.2% | 0.96 | 0.12 |
| NSCLC_38242124__IMC__88_A7,4 | Lung | Primary cancer | 2,848 | Stromal | 35.2% | 0.99 | 0.07 |
| NSCLC_38242124__IMC__88_A7,5 | Lung | Primary cancer | 2,444 | Tumor/Malignant | 52.0% | 0.97 | 0.10 |
| NSCLC_38242124__IMC__88_A7,6 | Lung | Primary cancer | 4,004 | Tumor/Malignant | 67.0% | 0.98 | 0.08 |
| NSCLC_38242124__IMC__88_A7,7 | Lung | Primary cancer | 3,483 | Tumor/Malignant | 73.6% | 0.99 | 0.03 |
| NSCLC_38242124__IMC__88_A7,8 | Lung | Primary cancer | 3,840 | Tumor/Malignant | 89.6% | 1.00 | 0.02 |
| NSCLC_38242124__IMC__88_A7,9 | Lung | Primary cancer | 2,058 | Other | 30.6% | 0.34 | 1.07 |
| NSCLC_38242124__IMC__88_A8,1 | Lung | Primary cancer | 3,439 | Tumor/Malignant | 29.0% | 0.98 | 0.10 |
| NSCLC_38242124__IMC__88_A8,10 | Lung | Primary cancer | 2,277 | Tumor/Malignant | 45.9% | 0.99 | 0.06 |
| NSCLC_38242124__IMC__88_A8,11 | Lung | Primary cancer | 2,263 | Tumor/Malignant | 50.2% | 0.76 | 0.58 |
| NSCLC_38242124__IMC__88_A8,12 | Lung | Primary cancer | 2,130 | Stromal | 37.6% | 0.53 | 0.93 |
Spatial Domain (Tier 3)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__88_A7,1 | Lung | Primary cancer | 3,240 | Fibroblast | 28.3% | 0.70 | 0.67 |
| NSCLC_38242124__IMC__88_A7,10 | Lung | Primary cancer | 2,113 | Tumor/Malignant cell | 50.5% | 0.94 | 0.20 |
| NSCLC_38242124__IMC__88_A7,11 | Lung | Primary cancer | 3,179 | Tumor/Malignant cell | 62.6% | 0.97 | 0.14 |
| NSCLC_38242124__IMC__88_A7,12 | Lung | Primary cancer | 861 | Fibroblast | 19.4% | 0.63 | 0.80 |
| NSCLC_38242124__IMC__88_A7,13 | Lung | Primary cancer | 3,282 | Tumor/Malignant cell | 47.1% | 0.93 | 0.28 |
| NSCLC_38242124__IMC__88_A7,14 | Lung | Primary cancer | 1,858 | Fibroblast | 52.7% | 0.92 | 0.23 |
| NSCLC_38242124__IMC__88_A7,15 | Lung | Primary cancer | 3,912 | Tumor/Malignant cell | 47.2% | 0.93 | 0.23 |
| NSCLC_38242124__IMC__88_A7,16 | Lung | Primary cancer | 3,866 | Tumor/Malignant cell | 58.9% | 0.94 | 0.18 |
| NSCLC_38242124__IMC__88_A7,2 | Lung | Primary cancer | 2,931 | Tumor/Malignant cell | 33.4% | 0.85 | 0.45 |
| NSCLC_38242124__IMC__88_A7,3 | Lung | Primary cancer | 3,583 | Tumor/Malignant cell | 55.4% | 0.96 | 0.13 |
| NSCLC_38242124__IMC__88_A7,4 | Lung | Primary cancer | 2,848 | Fibroblast | 57.6% | 0.91 | 0.26 |
| NSCLC_38242124__IMC__88_A7,5 | Lung | Primary cancer | 2,444 | Tumor/Malignant cell | 57.7% | 0.94 | 0.16 |
| NSCLC_38242124__IMC__88_A7,6 | Lung | Primary cancer | 4,004 | Tumor/Malignant cell | 67.3% | 0.98 | 0.08 |
| NSCLC_38242124__IMC__88_A7,7 | Lung | Primary cancer | 3,483 | Tumor/Malignant cell | 81.9% | 0.97 | 0.08 |
| NSCLC_38242124__IMC__88_A7,8 | Lung | Primary cancer | 3,840 | Tumor/Malignant cell | 92.1% | 0.99 | 0.03 |
| NSCLC_38242124__IMC__88_A7,9 | Lung | Primary cancer | 2,058 | Other | 30.9% | 0.34 | 1.12 |
| NSCLC_38242124__IMC__88_A8,1 | Lung | Primary cancer | 3,439 | Tumor/Malignant cell | 34.4% | 0.95 | 0.19 |
| NSCLC_38242124__IMC__88_A8,10 | Lung | Primary cancer | 2,277 | Tumor/Malignant cell | 65.6% | 0.94 | 0.20 |
| NSCLC_38242124__IMC__88_A8,11 | Lung | Primary cancer | 2,263 | Tumor/Malignant cell | 51.6% | 0.90 | 0.36 |
| NSCLC_38242124__IMC__88_A8,12 | Lung | Primary cancer | 2,130 | Fibroblast | 36.1% | 0.54 | 0.89 |